rs1114167666

Positions:

• chr10-87957953-GCCGTTA-G

Variant summary

Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM1 PM2 PM4 PP3 PP5_Moderate

The NM_000314.8(PTEN):​c.738_743delGTTACC​(p.Leu247_Pro248del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. P246P) has been classified as Benign.

• Frequency: Genomes: not found (cov: 32)
• Consequence: PTEN NM_000314.8 disruptive_inframe_deletion
• Clinical Significance: Likely pathogenic criteria provided, single submitter P:1
• Conservation: PhyloP100: 7.62

Genes affected

PTEN (HGNC:9588): (phosphatase and tensin homolog) This gene was identified as a tumor suppressor that is mutated in a large number of cancers at high frequency. The protein encoded by this gene is a phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase. It contains a tensin like domain as well as a catalytic domain similar to that of the dual specificity protein tyrosine phosphatases. Unlike most of the protein tyrosine phosphatases, this protein preferentially dephosphorylates phosphoinositide substrates. It negatively regulates intracellular levels of phosphatidylinositol-3,4,5-trisphosphate in cells and functions as a tumor suppressor by negatively regulating AKT/PKB signaling pathway. The use of a non-canonical (CUG) upstream initiation site produces a longer isoform that initiates translation with a leucine, and is thought to be preferentially associated with the mitochondrial inner membrane. This longer isoform may help regulate energy metabolism in the mitochondria. A pseudogene of this gene is found on chromosome 9. Alternative splicing and the use of multiple translation start codons results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2015]

PTEN (HGNC:):

ACMG classification

Verdict is Likely_pathogenic. Variant got 9 ACMG points.

• PM1: In a strand (size 21) in uniprot entity PTEN_HUMAN there are 7 pathogenic changes around while only 0 benign (100%) in NM_000314.8
• PM2: Very rare variant in population databases, with high coverage
• PM4: Nonframeshift variant in NON repetitive region in NM_000314.8.
• PP3: No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
• PP5: Variant 10-87957953-GCCGTTA-G is Pathogenic according to our data. Variant chr10-87957953-GCCGTTA-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 428252.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
PTEN	NM_000314.8	c.738_743delGTTACC	p.Leu247_Pro248del	disruptive_inframe_deletion	7/9	ENST00000371953.8	NP_000305.3
PTEN	NM_001304717.5	c.1257_1262delGTTACC	p.Leu420_Pro421del	disruptive_inframe_deletion	8/10		NP_001291646.4
PTEN	NM_001304718.2	c.147_152delGTTACC	p.Leu50_Pro51del	disruptive_inframe_deletion	7/9		NP_001291647.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
PTEN	ENST00000371953.8	c.738_743delGTTACC	p.Leu247_Pro248del	disruptive_inframe_deletion	7/9	1	NM_000314.8	ENSP00000361021.3

Frequencies

GnomAD3 genomes Cov.: 32

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome Cov.: 32

ClinVar

Significance: Likely pathogenic

Submissions summary: Pathogenic:1

Revision: criteria provided, single submitter

Submissions by phenotype

Hereditary cancer-predisposing syndrome Pathogenic:1

Likely pathogenic, criteria provided, single submitter

clinical testing

Ambry Genetics

Oct 22, 2019

The c.738_743delGTTACC variant (also known as p.L247_P248del) is located in coding exon 7 of the PTEN gene. This variant results from an in-frame deletion of GTTACC between nucleotide positions 738 and 743. This results in the deletion of a highly conserved leucine residue at codon 247 and a highly conserved proline residue at codon 248. This variant was identified in an individual meeting clinical diagnostic criteria for PTEN hamartoma tumor syndrome (Ambry internal data). This variant also demonstrated aberrant activity in cell viability assays (Ng PK et al. Cancer Cell, 2018 03;33:450-462.e10). Based on internal structural analysis, p.L247 and p.P248 reside within a β-sandwich on the C2 domain directed towards the phosphatase domain and the p.L247_P248del alteration results in a distortion of this β-sandwich significantly altering the surrounding residues (Lee JO et al. Cell, 1999 Oct;99:323-34). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD) (Lek M et al. Nature, 2016 08;536:285-91). In addition, this alteration is predicted to be deleterious by PROVEAN in silico analysis (Choi Y et al., Bioinformatics 2015 Aug; 31(16):2745-7). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -

Computational scores

Source: dbNSFP v4.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1114167666; hg19: chr10-89717710;